BIOMAT Database Logo BIOMAT Database Logo

Incompatibility of aluminum-containing iv administration equipment with cis-dichlorodiammineplatinum(II) administration. 1979

A W Prestayko, and M Cadiz, and S T Crooke

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000535 Aluminum A metallic element that has the atomic number 13, atomic symbol Al, and atomic weight 26.98. Aluminium,Aluminium-27,Aluminum-27,Aluminium 27,Aluminum 27
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution

Related Publications

A W Prestayko, and M Cadiz, and S T Crooke
Nephrotoxicity of cis-dichlorodiammineplatinum(II).
January 1979, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
[Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
April 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
A W Prestayko, and M Cadiz, and S T Crooke
Interaction of cis-dichlorodiammineplatinum (II) with DNA.
December 1971, Biochimica et biophysica acta,
A W Prestayko, and M Cadiz, and S T Crooke
Antitumor activity of cis-dichlorodiammineplatinum(II).
January 1979, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
Combination chemotherapy in vitro with cis-dichlorodiammineplatinum(II).
November 1976, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment.
December 1979, Cancer,
A W Prestayko, and M Cadiz, and S T Crooke
cis-Dichlorodiammineplatinum(II) in childhood cancer.
January 1979, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
Mechanism of action of cis-dichlorodiammineplatinum(II).
January 1979, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
Pharmacokinetics of non-protein-bound platinum species following administration of cis-dichlorodiammineplatinum(II).
January 1979, Cancer treatment reports,
A W Prestayko, and M Cadiz, and S T Crooke
Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas.
June 1982, Cancer treatment reviews,
Copied contents to your clipboard!